CTOs on the Move

Unum Therapeutics

www.unumrx.com

 
Unum is a Cambridge, MA-based cellular therapeutics company ushering in a new wave of innovation in cancer immunotherapy. Unum has built an antibody-coupled T-cell receptor (ACTR) platform that, when combined with tumor-specific antibodies, directs an individual’s cytotoxic T-lymphocytes (CTLs) to kill tumor cells. In contrast to other approaches that hit a single target and treat a narrow set of tumors, Unum’s approach is not restricted by antigens and may have applications for treating many types of cancers.   Our lead program based on ACTR technology is expected to enter Phase I clinical testing soon to assess safety and efficacy in certain forms ...
  • Number of Employees: 0-25
  • Annual Revenue: $50-100 Million
  • www.unumrx.com
  • One Broadway 4th Floor
    Cambridge, MA USA 02142
  • Phone: 617.843.5032

Executives

Name Title Contact Details

Funding

Unum Therapeutics raised $65M on 06/11/2015
Unum Therapeutics raised $104.4M on 07/06/2020

Similar Companies

Cardinal Health

Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States.

Sunrise Pharmaceutical Inc

Sunrise Pharmaceutical Inc is a Rahway, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Las Cumbres

Homecure

Homecure is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OptionCare

Option Care is a leading provider of home and alternate treatment site infusion services. With a staff of more than 1,700 clinical experts – including specially trained infusion nurses, infusion pharmacists and registered dietitians – Option Care treats patients with a wide range of acute and chronic conditions. Comprehensive therapy management programs are offered for patients with nutrition disorders, bleeding disorders and heart failure, as well as those needing immunoglobulin (IG) therapy and anti-infective therapy. Option Care is able to provide services to 92% of the nation`s population through more than 90 infusion pharmacies and 100 alternate treatment sites across the country.